1. Marjon, Katya, Cameron, Michael J, Quang, Phong, Biller, Scott A, Marks, Kevin M. 2016. MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis. In Cell reports, 15, 574-587. doi:10.1016/j.celrep.2016.03.043. https://pubmed.ncbi.nlm.nih.gov/27068473/
2. Chen, Anqun, Feng, Ye, Lai, Han, Lee, Kyung, He, John Cijiang. . Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression. In The Journal of clinical investigation, 130, 5523-5535. doi:10.1172/JCI140155. https://pubmed.ncbi.nlm.nih.gov/32634130/
3. Handle, Florian, Puhr, Martin, Gruber, Martina, De Wulf, Peter, Culig, Zoran. 2023. The Oncogenic Protein Kinase/ATPase RIOK1 Is Up-Regulated via the c-myc/E2F Transcription Factor Axis in Prostate Cancer. In The American journal of pathology, 193, 1284-1297. doi:10.1016/j.ajpath.2023.05.013. https://pubmed.ncbi.nlm.nih.gov/37301535/
4. Shechter, Sharon, Ya'ar Bar, Sapir, Khattib, Hamdan, Gage, Matthew J, Avni, Dorit. 2023. Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells. In Molecules (Basel, Switzerland), 28, . doi:10.3390/molecules28114452. https://pubmed.ncbi.nlm.nih.gov/37298928/
5. Weinberg, Florian, Reischmann, Nadine, Fauth, Lisa, Zeiser, Robert, Brummer, Tilman. 2017. The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior. In EBioMedicine, 20, 79-97. doi:10.1016/j.ebiom.2017.04.015. https://pubmed.ncbi.nlm.nih.gov/28499923/
智鼠故事 
